Bruker (BRKR) Cash from Investing Activities (2010 - 2026)
Bruker's (BRKR) quarterly Cash from Investing Activities came in at -$25.3 million in Q2 2026, up 72.23% on a YoY basis from -$14.7 million in Q2 2025, and up 36.27% quarter-over-quarter from -$39.7 million in Q1 2026.
Analysis
Bruker (BRKR) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported Cash from Investing Activities for 17 consecutive years, with -$25.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities rose 72.23% year-over-year to -$25.3 million; the trailing twelve-month figure through Jun 2026 stood at -$144.3 million (up 41.2% YoY), and the FY2025 full-year result was -$196.5 million, up 88.82% from the prior year.
- Cash from Investing Activities climbed to -$25.3 million in Q2 2026 per BRKR's latest filing, from -$39.7 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $57.1 million in Q2 2022 and bottomed at -$1.3 billion in Q2 2024.
- Historically, Cash from Investing Activities has averaged -$144.2 million across 5 years, with a median of -$59.1 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities soared 179.97% in 2022, then sank 4995.77% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$149.3 million in 2022, then soared by 75.35% to -$36.8 million in 2023, then sank by 64.67% to -$60.6 million in 2024, then increased by 8.42% to -$55.5 million in 2025, then surged by 54.41% to -$25.3 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$25.3 million, -$39.7 million, and -$55.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -1.03 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -122.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -3.51 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -7.06 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -66.70 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -2.09 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -7.74 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -25.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.30 Mn |
| Mar 31, 2026 | -39.70 Mn |
| Dec 31, 2025 | -55.50 Mn |
| Sep 30, 2025 | -23.80 Mn |
| Jun 30, 2025 | -91.10 Mn |
| Mar 31, 2025 | -26.10 Mn |
| Dec 31, 2024 | -60.60 Mn |
| Sep 30, 2024 | -67.60 Mn |
| Jun 30, 2024 | -1.32 Bn |
| Mar 31, 2024 | -304.20 Mn |
| Dec 31, 2023 | -36.80 Mn |
| Sep 30, 2023 | -155.00 Mn |
| Jun 30, 2023 | -26.00 Mn |
| Mar 31, 2023 | -108.20 Mn |
| Dec 31, 2022 | -149.30 Mn |
| Sep 30, 2022 | -57.60 Mn |
| Jun 30, 2022 | 57.10 Mn |
| Mar 31, 2022 | -101.80 Mn |
| Dec 31, 2021 | -48.60 Mn |
| Sep 30, 2021 | -48.40 Mn |